{
    "2021-11-11": [
        [
            {
                "time": "2021-11-11",
                "original_text": "希望破灭！天价药没有双十一大促，120万一针抗癌神药或无缘医保",
                "features": {
                    "keywords": [
                        "天价药",
                        "抗癌神药",
                        "医保"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-11",
                "original_text": "雪扬科技起诉复星集团等侵犯商业秘密 诉讼纠纷",
                "features": {
                    "keywords": [
                        "雪扬科技",
                        "复星集团",
                        "商业秘密",
                        "诉讼纠纷"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-11",
                "original_text": "斥资8亿，复星再控股一家三级医院",
                "features": {
                    "keywords": [
                        "复星",
                        "控股",
                        "三级医院"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "健康服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-11",
                "original_text": "Wind医药：每日行业动态（2021-11-11）",
                "features": {
                    "keywords": [
                        "Wind医药",
                        "行业动态"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-11",
                "original_text": "国家医保谈判“降价”依旧是主旋律，感染药及PD(L)-1新适应症成角逐热点",
                "features": {
                    "keywords": [
                        "国家医保",
                        "降价",
                        "感染药",
                        "PD(L)-1",
                        "新适应症"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}